⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

REGN

Regeneron Pharmaceuticals, Inc.

Healthcare · Biotechnology

807.65USD

-2.6600 (-0.33%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 807.65
P/E19.3
Dvd Ind Yld0.4%
P/B2.63
P/S5.4
Curr EV/T12M EBITDA17.3
Mkt Cap (USD)83.4B
Curr EV (USD)75.6B
2)

Per Share Data

EPS T12M40.38
DPS3.57
Bk Val Per Sh316.11
Rev/Sh146.55
Cash/Sh80.06
Curr Shares Out101.1M
FCF/Sh35.48
3)

Cash Flow Analysis

P/CF17.8
Curr P/FCF22.2
CF/NI1.1
Dvd P/O8.7%
Cash Gen/Cash Reqd3.6
Csh Dvd Cov12.4
CFO/Sales30.1%
Eff Interest Rate2.8%
4)

Growth Potential

Dil EPS 1Y Gr8.2%
Cap 1Y Gr6.1%
BPS 1Y Gr12.9%
R&D To Sales40.4%
Retention Rate91.3%
Rev 1Y Gr1.0%
FCF 1Y Gr11.3%
Assets 1Y Gr7.4%
5)

Profitability

EBITDA4.4B
EBIT3.8B
Operating Margin24.7%
Pretax Margin33.3%
Net Margin27.9%
ROA10.8%
ROE14.0%
ROC9.1%
Asset Turnover0.39
6)

Structure

Current Ratio3.34
Quick Ratio2.63
Debt/Assets8.4%
Debt/Com Eq11.0%
Net Debt/EBITDA0.24
Tot Debt/Capital9.9%
Gross Margin37.7%
EBIT/Int Exp69.4

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.